# Use of Data Monitoring Committees in Clinical Trials - FDA Guidance Document

Source: https://www.keypedia.com/guidances/guidance-document/use-of-data-monitoring-committees-in-clinical-trials/9d0ee35d-4fcc-4c44-88ac-f56c6a60187b

> FDA guidance document: Use of Data Monitoring Committees in Clinical Trials. Issue date: February 13, 2024. Get complete insights and analysis.

---

## Details

- Title: Use of Data Monitoring Committees in Clinical Trials
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2024-02-13
- Comment Close Date: 2024-04-15
- Last Changed: 2024-02-13
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2001-D-0219">FDA-2001-D-0219</a>

## Related Documents

- [Use of Bayesian Methodology in Clinical Trials of Drug and Biological Products: Draft Guidance for Industry](https://www.keypedia.com/guidances/guidance-document/use-of-bayesian-methodology-in-clinical-trials-of-drug-and-biological-products-draft-guidance-for-industry/8e9c345e-0994-47b3-8d6c-054f04ed937e)
- [Protocol Deviations for Clinical Investigations of Drugs, Biological Products, and Devices](https://www.keypedia.com/guidances/guidance-document/protocol-deviations-for-clinical-investigations-of-drugs-biological-products-and-devices/12be365f-ede2-4671-b6b7-8da74c7c3635)
- [Expanded Access to Investigational Drugs for Treatment Use:  Questions and Answers](https://www.keypedia.com/guidances/guidance-document/expanded-access-to-investigational-drugs-for-treatment-use-questions-and-answers/c8db4f04-043a-440b-838b-50bc0e9b17c9)